Q4 2022 Results slide image

Q4 2022 Results

Company overview Financial review 2023 priorities Appendix Vas Narasimhan, M.D. Chief Executive Officer 46 Investor Relations | Q4 2022 Results NOVARTIS | Reimagining Medicine
View entire presentation